Efficacy of Genital Chlamidiae Trachomatis Treatment in Women of Reproductive Age
Authors:
- Aleksandra DimitrijevicADAleksandra Dimitrijevic
- Zoran ProtrkaZPZoran Protrka
- Nikola JovicNJNikola Jovic
- Petar ArsenijevicPAPetar Arsenijevic
Open Access
- 1 June 2018
- journal article
- Published by Walter de Gruyter GmbH in Serbian Journal of Experimental and Clinical Research
- Vol. 19 (2) , 151-157
Abstract
Cervicitis is inflammation of the cervix, and the causes of such inflammation may include infection from certain sexually transmitted diseases (STDs), injury to the cervix from a foreign body inserted into the vagina (for example, birth control devices such as a cervical cap or diaphragm), or cervical cancer, whose course can be subacute or chronic. Our research aimed to test the efficacy of the proposed treatment protocol for chlamydia trachomatis distal genital infections in reproductive women. This single-centre, randomized, quasi-experimental prospective study was conducted among 40 women with diagnosed Chlamydia Trachomatis (CT) cervical infections who were diagnosed and treated at the Clinic of Obstetrics and Gynaecology in the Clinical Center Kragujevac in Serbia from December 2014 to January 2015. Patients were divided into two groups according to the treatment method: the tetracycline group (n=20), with doxiciclyn (Dovicin®) given at a dose of 100 mg twice per day for 10 days and 100 mg per day for the next 10 days, and the macrolides group (n=20), with azithromycin (Hemomycin®) at a dose of 1000 mg per day, divided into four doses or a single dose per day. Treatment with doxycycline proved to be statistically more effective compared to treatment with azithromycin. Our results confirm that the outcome of infections caused by C. trachomatis depends solely on the applied therapy and management, but extensive prospective studies in a female cohort that includes more parameters, such as potential age related, dose-dependent and adherence variability, are necessary to determine and confirm the best choice for treatment of CT cervicitis.Keywords
This publication has 7 references indexed in Scilit:
- Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical TrialClinical Infectious Diseases, 2010
- 2010 European guideline for the management of Chlamydia trachomatis infectionsInternational Journal of STD & AIDS, 2010
- Decreased Susceptibility to Azithromycin and Doxycycline in Clinical Isolates of Chlamydia trachomatis Obtained from Recurrently Infected Female Patients in IndiaChemotherapy, 2010
- The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-upInternational Journal of STD & AIDS, 2002
- A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor settingJournal of Antimicrobial Chemotherapy, 2002
- Urogenital Chlamydia trachomatis Serovars in Men and Women with a Symptomatic or Asymptomatic Infection: an Association with Clinical Manifestations?Journal of Clinical Microbiology, 2000
- The Cost Effectiveness of Azithromycin for Chlamydia trachomatis Infections in WomenSexually Transmitted Diseases, 1995